Psychiatric Comorbidity in Heart Failure: Associations With Length of Stay, Costs, and Mortality in a National Cohort

Objective To evaluate how specific psychiatric comorbidities relate to index length of stay (LOS), hospital costs, and in-hospital mortality during readmissions after HF hospitalization. Methods A retrospective cohort study was conducted using the 2016-2022 Nationwide Readmissions Database. Adults with a principal HF diagnosis were included. Psychiatric comorbidities were depression, anxiety, bipolar disorder, schizophrenia/psychotic disorders, post-traumatic stress disorder (PTSD), and substance use disorder (SUD). Outcomes were index LOS, inflation-adjusted costs, and in-hospital mortality during readmissions within 30 days and up to 1 year after discharge. Survey-weighted multivariable models adjusted for demographics, socioeconomic factors, hospital characteristics, discharge disposition, and comorbidity burden; P ≤ 0.001 was prespecified as the level of statistical significance. Results Among 31,886,859 weighted HF hospitalizations, psychiatric comorbidity was common. Anxiety was associated with longer LOS (β = 0.88 days; P < 0.001) and higher costs (β = $2779; P < 0.001) but there were no differences in 30-day or 1-year mortality. However, several diagnoses were associated with lower mortality, including depression (30-day OR = 0.86; 1-year OR = 0.86), bipolar disorder (0.66; 0.68), schizophrenia/psychotic disorders (0.68; 0.72), PTSD (0.73; 0.78), and SUD (0.87; 0.92) (all P < 0.001). Bipolar disorder showed the largest cost reduction ( β = −$1320; P < 0.001) compared to HF patients without bipolar disorder. Conclusion Psychiatric comorbidity in HF is common. Anxiety is associated with increased hospital utilization, but is not associated with mortality, whereas several other diagnoses are associated with lower mortality. Costs were lower for depression and bipolar disorder. These diagnosis-specific patterns support targeted screening, early consultation, and integrated consultation-liaison care pathways during HF hospitalization.

Authors

Institutions

Publication Details

Journal
The International Journal of Psychiatry in Medicine
Published
2026-06-29
DOI
https://doi.org/10.1177/00912174261465528
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychiatric Comorbidity in Heart Failure: Associations With Length of Stay, Costs, and Mortality in a National Cohort

Michael White, Austin A. Charles, Peter L. Ernst, Kyle E Thurmann et al.
The International Journal of Psychiatry in Medicine
Heart Failure Treatment and Management
article

Psychiatric Comorbidity in Heart Failure: Associations With Length of Stay, Costs, and Mortality in a National Cohort

Michael White, Austin A. Charles, Peter L. Ernst, Kyle E Thurmann, Paul T. Kang
article en

Abstract

Objective To evaluate how specific psychiatric comorbidities relate to index length of stay (LOS), hospital costs, and in-hospital mortality during readmissions after HF hospitalization. Methods A retrospective cohort study was conducted using the 2016-2022 Nationwide Readmissions Database. Adults with a principal HF diagnosis were included. Psychiatric comorbidities were depression, anxiety, bipolar disorder, schizophrenia/psychotic disorders, post-traumatic stress disorder (PTSD), and substance use disorder (SUD). Outcomes were index LOS, inflation-adjusted costs, and in-hospital mortality during readmissions within 30 days and up to 1 year after discharge. Survey-weighted multivariable models adjusted for demographics, socioeconomic factors, hospital characteristics, discharge disposition, and comorbidity burden; P ≤ 0.001 was prespecified as the level of statistical significance. Results Among 31,886,859 weighted HF hospitalizations, psychiatric comorbidity was common. Anxiety was associated with longer LOS (β = 0.88 days; P < 0.001) and higher costs (β = $2779; P < 0.001) but there were no differences in 30-day or 1-year mortality. However, several diagnoses were associated with lower mortality, including depression (30-day OR = 0.86; 1-year OR = 0.86), bipolar disorder (0.66; 0.68), schizophrenia/psychotic disorders (0.68; 0.72), PTSD (0.73; 0.78), and SUD (0.87; 0.92) (all P < 0.001). Bipolar disorder showed the largest cost reduction ( β = −$1320; P < 0.001) compared to HF patients without bipolar disorder. Conclusion Psychiatric comorbidity in HF is common. Anxiety is associated with increased hospital utilization, but is not associated with mortality, whereas several other diagnoses are associated with lower mortality. Costs were lower for depression and bipolar disorder. These diagnosis-specific patterns support targeted screening, early consultation, and integrated consultation-liaison care pathways during HF hospitalization.

The International Journal of Psychiatry in Medicine
Creighton University (US)
Good health and well-being
Openalex Percentile: Top 7%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.